%0 Generic %A Yuan, Yanhong %A Che, Xiajing %A Ni, Zhaohui %A Zhong, Yifei %A Qi, Yinghui %A Shao, Xinghua %A Wang, Qin %A Cao, Liou %A Zhang, Minfang %A Xie, Yuanyuan %A Qi, Chaojun %A Tian, Lei %A Mou, Shan %D 2015 %T Demographics and Clinicopathologic Characteristics of Patients with IgAN. %U https://plos.figshare.com/articles/dataset/_Demographics_and_Clinicopathologic_Characteristics_of_Patients_with_IgAN_/1545150 %R 10.1371/journal.pone.0137870.t001 %2 https://plos.figshare.com/ndownloader/files/2266331 %K diastolic blood pressure %K 489 patients %K validation cohort.ConclusionsThis study %K Current Therapy Regimen %K baseline diastolic blood pressure %K Ren Ji Hospital %K dbp %K igan %K multivariate Cox analysis %K relapse %X

Values are presented as the means ± standard deviation (SD) if the variables showed a normal distribution and as medians (IQR) if the variables did not show a normal distribution; n (%) was used for the categorical variables.

SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial blood pressure; SCr: serum creatinine; BUN: blood urea nitrogen; eGFR: estimated glomerular filtration rate; UA: serum uric acid; Hb: hemoglobin; ALB: serum albumin; UPE: 24-h urinary protein excretion; uRBC/HP: hematuria; TA-ALB: time-averaged serum albumin; TA-SCr: time-averaged serum creatinine; TA-eGFR: time-averaged eGFR; TA-UPE: time-averaged 24-h urinary protein excretion; Peak UPE: maximum level of UPE during follow-up; Peak SCr: maximum level of SCr during follow-up; Minimum ALB: minimum level of ALB; Minimum eGFR: minimum eGFR during follow-up; UPE ratio: (UPE at follow-up—baseline UPE) / baseline UPE.

Demographics and Clinicopathologic Characteristics of Patients with IgAN.

%I PLOS ONE